Title : Effects of Strong CYP2C8 or CYP3A Inhibition and CYP3A Induction on the Pharmacokinetics of Brigatinib, an Oral Anaplastic Lymphoma Kinase Inhibitor, in Healthy Volunteers.

Pub. Date : 2020 Feb

PMID : 31287236






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A 3-arm, open-label, randomized, single-dose, fixed-sequence crossover study was conducted to characterize the effects of the strong inhibitors gemfibrozil (of CYP2C8) and itraconazole (of CYP3A) and the strong inducer rifampin (of CYP3A) on the single-dose pharmacokinetics of brigatinib. Itraconazole cytochrome P450 family 3 subfamily A member 4 Homo sapiens